You are here: Home » Companies » Results
D-Mart Q2 consolidated net profit increases twofold to Rs 417 crore
Business Standard

Q2 preview: Non-Covid revenues to hint at normalisation for healthcare cos

Companies may, however, report sequential drop in numbers as Q1FY22 coincided with outbreak of second Covid wave, say brokerages

Topics
Q2 results | pharmaceutical firms | Sun Pharma

Sohini Das  |  Mumbai 



Giving steroids to subdue inflammatory response to Covid increased significantly during India’s second Covid wave, triggering more cases of a fungal infection. (Photo: Bloomberg)
Representational image

The healthcare sector – pharmaceuticals, hospitals and diagnostics – is likely to show signs of normalisation with non-Covid-19 revenues growing in the September quarter (Q2) of 2021-22, say brokerages.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Sun, October 17 2021. 16:08 IST

RECOMMENDED FOR YOU

.